Myxoid glioneuronal tumor, <i>PDGFRA</i> p.K385‐mutant: clinical, radiologic, and histopathologic featuresCalixto‐Hope G. Lucas, David A. Solomon, Angelica R. Putnam et al.|Brain Pathology|2019Cited by 75
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1Calixto‐Hope G. Lucas, David A. Solomon, Emily A. Sloan et al.|Acta Neuropathologica|2022Cited by 50
Prospective genomically guided identification of “early/evolving” and “undersampled” IDH-wildtype glioblastoma leads to improved clinical outcomesYalan Zhang, David A. Solomon, Calixto‐Hope G. Lucas et al.|Neuro-Oncology|2022Cited by 31
Novel <i>SOX10</i> indel mutations drive schwannomas through impaired transactivation of myelination gene programsErik A. Williams, David A. Solomon, Ajay Ravindranathan et al.|Neuro-Oncology|2023Cited by 31
GENO-25HYPERMUTATION AND MALIGNANT PROGRESSION IN AN EXPANDED COHORT OF TEMOZOLOMIDE-TREATED LOW-GRADE GLIOMA PATIENTSTali Mazor, J Costello, Brett Johnson et al.|Neuro-Oncology|2015Cited by 2